|
PRINT ISSN : 2319-7692
Online ISSN : 2319-7706 Issues : 12 per year Publisher : Excellent Publishers Email : editorijcmas@gmail.com / submit@ijcmas.com Editor-in-chief: Dr.M.Prakash Index Copernicus ICV 2018: 95.39 NAAS RATING 2020: 5.38 |
In recent times, the treatment of Staphylococcus aureus infection has become problematic because of emergence of resistance to antibiotics which is a cause of concern for all the clinicians and microbiologists worldwide. Infections caused by MRSA have been associated with high morbidity and mortality rates. Hence this study was conducted to know the prevalence of Methicillin resistant Staphylococcus aureus [MRSA] isolates in various clinical specimens and to determine the sensitivity of these isolates to different antimicrobial agents. Among the 161 clinical isolates of S. aureus, highest isolation was from pus samples (64%), followed by blood (13%) and respiratory secretions (13%). 82 (51%) were identified as MRSA by Cefoxitin disc diffusion method and maximum MRSA were again isolated from pus (61%). Comparatively MRSA prevalence is more in males (73%) and most common affected age group was 21-30 years. All MRSA strains were resistant to penicillin (100%), followed by ciprofloxacin (93%) and erythromycin (61%). We found statistically significant differences in the drug susceptibility pattern of MRSA & MSSA for Penicillin, Clindamycin, Erythromycin, Ciprofloxacin, Co-trimoxazole and Levofloxacin. MDR-MRSA strains in our study are 45%. Hence we suggest, more and more studies in future are needed to fight against rising menace of antibiotic resistance among Staphylococcus aureus